所有图片(1)
About This Item
经验公式（希尔记法）:
C22H43N5O13 · xH2O
CAS号:
分子量:
585.60 (anhydrous basis)
Beilstein:
1445422
EC 号:
MDL编号:
UNSPSC代码:
51281632
PubChem化学物质编号:
NACRES:
NA.85
推荐产品
生物来源
synthetic
质量水平
表单
powder
颜色
white to almost white
抗生素抗菌谱
Gram-negative bacteria
mycobacteria
作用机制
protein synthesis | interferes
储存温度
2-8°C
SMILES字符串
O.NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
InChI
1S/C22H43N5O13.H2O/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21;/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36);1H2/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+;/m0./s1
InChI key
DTSOZYYWEZJFSS-XTHCGPPUSA-N
一般描述
化学结构：氨基糖苷类
应用
阿米卡星水合物用于对诸如 结核分枝杆菌 和 嗜艾利希体 等微生物的抗菌敏感性研究。
生化/生理作用
阿米卡星通过与 30S 核糖体亚基结合，诱导 mRNA 误读，从而抑制细菌蛋白质合成。干扰 tRNA 从 A 位点到 P 位点的移位。
包装
5G
其他说明
保存于密闭容器内，置于干燥通风处。
储存分类代码
11 - Combustible Solids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
法规信息
监管及禁止进口产品
从最新的版本中选择一种：
分析证书(COA)
Lot/Batch Number
H W Horowitz et al.
Antimicrobial agents and chemotherapy, 45(3), 786-788 (2001-02-22)
Human granulocytic ehrlichiosis is a recently described disease caused by an obligate intracellular gram-negative organism recently named Ehrlichia phagocytophila. To expand our knowledge of the susceptibility of E. phagocytophila, we tested six New York State isolates for susceptibility to 12
G J Alangaden et al.
Antimicrobial agents and chemotherapy, 42(5), 1295-1297 (1998-05-21)
An A1400G mutation of the rrs gene was identified in Mycobacterium tuberculosis (MTB) strain ATCC 35827 and in 13 MTB clinical isolates resistant to amikacin-kanamycin (MICs, >128 microg/ml). High-level cross-resistance may result from such a mutation since MTB has a
M P Goren et al.
The Pediatric infectious disease journal, 8(5), 278-282 (1989-05-01)
A three-drug antibiotic regimen including vancomycin and amikacin has been recommended as effective treatment in clinical settings in which Gram-positive bacteremias are a serious problem. To determine if vancomycin potentiates the tubular proteinuria associated with amikacin therapy, we studied febrile
P Van der Auwera
The Journal of antimicrobial chemotherapy, 27 Suppl C, 63-71 (1991-05-01)
The pharmacokinetic parameters of amikacin given once daily were compared to those of amikacin given bd at different daily dosages. In adult patients, 'peak' serum concentrations (30 min after 30 min infusion) were linearly proportional to the dose given with
Amikacin.
R D Meyer
Annals of internal medicine, 95(3), 328-332 (1981-09-01)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门